{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:49:07Z","timestamp":1780372147241,"version":"3.54.1"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>In colorectal cancer (CRC) screening, too many patients fail to receive follow-up colonoscopy after an abnormal fecal immunochemical test (FIT), and transportation is a frequently reported barrier.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine the outcomes and cost-effectiveness of providing a rideshare intervention to patients with abnormal FIT results.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>The CRC-Simulated Population Model for Incidence and Natural History microsimulation model was used to simulate the outcomes and cost-effectiveness of a rideshare intervention to improve colonoscopy completion in a population-based CRC screening program. Cohorts were adherent to annual FIT-based screening; baseline analyses assumed that 35% would complete a follow-up colonoscopy. Data were analyzed from November 14, 2023, to July 8, 2025.<\/jats:p><\/jats:sec>Intervention<\/jats:title>A $40 or $100 rideshare to increase completion of follow-up colonoscopy.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Lifetime outcomes included the number of CRC cases, deaths, and life-years gained (LYG) per 1000 people screened and costs associated with improved completion of a colonoscopy after an abnormal FIT result.<\/jats:p><\/jats:sec>Results<\/jats:title>Four single-age cohorts (ages 45, 55, 65, and 70 years on January 1, 2024) of 10 million people each were simulated. In cohorts with similar sex distribution as the US population (aged 45 years, 50.0% male; aged 55 years, 49.4% male); aged 65 years, 48.0% male; and aged 70 years, 46.9% male), compared with no intervention, using a rideshare intervention starting at age 45 years that costs $100 per ride to increase colonoscopy completion from 35% to 70% was associated with a reduction in CRC cases per 1000 by 26.3% (30.7 vs 41.6 cases per 1000), CRC deaths per 1000 by 32.5% (9.8 vs 14.6 cases per 1000), 24.9 LYG per 1000, and at $100 per ride cost $43\u202f308 per 1000 people screened and saved $330\u202f587 per 1000 people screened.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In a microsimulation model, increasing colonoscopy completion in a population with abnormal FIT results via a rideshare intervention was cost saving up to $100 per ride due to the combined outcome of cancer prevention and early detection.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.30515","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:31:33Z","timestamp":1756999893000},"page":"e2530515","source":"Crossref","is-referenced-by-count":4,"title":["Modeled Cost-Effectiveness of a Rideshare Program to Facilitate Colonoscopy Completion"],"prefix":"10.1001","volume":"8","author":[{"given":"Rachel B.","family":"Issaka","sequence":"first","affiliation":[{"name":"Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington"},{"name":"Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, Washington"},{"name":"Division of Gastroenterology, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Matrajt","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington"},{"name":"Department of Applied Mathematics, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Nascimento","family":"de Lima","sequence":"additional","affiliation":[{"name":"Engineering and Applied Sciences Department, RAND Corporation, Arlington, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Rutter","sequence":"additional","affiliation":[{"name":"Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington"},{"name":"Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"1","key":"zoi250859r1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"zoi250859r3","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1002\/cncr.32440","article-title":"Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 FEDERALLY QUALIFIED HEALTH CENTERS in Southern California: opportunities for improving screening outcomes.","volume":"125","author":"Bharti","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"zoi250859r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51384","article-title":"Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017-2020.","volume":"6","author":"Mohl","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi250859r5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/gutjnl-2020-322192","article-title":"Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.","volume":"71","author":"Zorzi","year":"2022","journal-title":"Gut"},{"issue":"4","key":"zoi250859r6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.gie.2023.05.043","article-title":"Transportation barriers and endoscopic procedures: barriers, legal challenges, and strategies for GI endoscopy units.","volume":"98","author":"Kwok","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"zoi250859r7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cgh.2023.09.030","article-title":"Health system-provided rideshare is safe and addresses barriers to colonoscopy completion.","volume":"22","author":"Issaka","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"zoi250859r8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12889-022-13149-1","article-title":"Effect of interventions for non-emergent medical transportation: a systematic review and meta-analysis.","volume":"22","author":"Shekelle","year":"2022","journal-title":"BMC Public Health"},{"key":"zoi250859r9","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2021.799816","article-title":"Operationalizing a rideshare intervention for colonoscopy completion: barriers, facilitators, and process recommendations.","volume":"1","author":"Bell-Brown","year":"2022","journal-title":"Front Health Serv"},{"issue":"2","key":"zoi250859r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2024.100188","article-title":"Implementing an organized colorectal cancer screening program: lessons learned from an academic-community practice.","volume":"3","author":"Kimura","year":"2024","journal-title":"AJPM Focus"},{"issue":"3","key":"zoi250859r11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/1471-0528.17012","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.","volume":"129","author":"Husereau","year":"2022","journal-title":"BJOG"},{"issue":"4","key":"zoi250859r13","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1214\/19-AOAS1279","article-title":"Microsimulation model calibration using incremental mixture approximate bayesian computation.","volume":"13","author":"Rutter","year":"2019","journal-title":"Ann Appl Stat"},{"issue":"19","key":"zoi250859r14","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2021.5746","article-title":"Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force.","volume":"325","author":"Knudsen","year":"2021","journal-title":"JAMA"},{"issue":"23","key":"zoi250859r15","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1001\/jama.2016.6828","article-title":"Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force.","volume":"315","author":"Knudsen","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"zoi250859r17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.7326\/M24-0375","article-title":"The annual cost of cancer screening in the United States.","volume":"177","author":"Halpern","year":"2024","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi250859r18","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States.","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"zoi250859r19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2025.7515","article-title":"Clinical validation of a circulating tumor DNA-based blood test to screen for colorectal cancer.","volume":"334","author":"Shaukat","year":"2025","journal-title":"JAMA"},{"issue":"11","key":"zoi250859r20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa2304714","article-title":"A cell-free DNA blood-based test for colorectal cancer screening.","volume":"390","author":"Chung","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi250859r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.54938","article-title":"Cost-effectiveness of noninvasive colorectal cancer screening in community clinics.","volume":"8","author":"Nascimento de Lima","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi250859r22","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.cgh.2024.07.001","article-title":"Interventions to increase follow-up of abnormal stool-based colorectal cancer screening tests in safety net settings: a systematic review.","volume":"22","author":"Issaka","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"zoi250859r23","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/j.amepre.2016.02.025","article-title":"Racial\/ethnic disparities in colorectal cancer screening across healthcare systems.","volume":"51","author":"Burnett-Hartman","year":"2016","journal-title":"Am J Prev Med"},{"issue":"11","key":"zoi250859r24","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/jnci\/djae140","article-title":"Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.","volume":"116","author":"Alagoz","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi250859r25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.7326\/ANNALS-24-01885","article-title":"Patient navigation to improve colonoscopy completion after an abnormal stool test result: a randomized controlled trial.","volume":"178","author":"Coronado","year":"2025","journal-title":"Ann Intern Med"},{"issue":"16","key":"zoi250859r26","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1007\/s11606-023-08321-1","article-title":"Essential not supplemental: Medicare Advantage members\u2019 use of non-emergency medical transportation (NEMT).","volume":"38","author":"Razon","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"10","key":"zoi250859r27","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1158\/2767-9764.CRC-23-0322","article-title":"Impact of eliminating cost-sharing by Medicare beneficiaries for follow-up colonoscopy after a positive stool-based colorectal cancer screening test.","volume":"3","author":"Fendrick","year":"2023","journal-title":"Cancer Res Commun"},{"key":"zoi250859r2","unstructured":"National Colorectal Cancer Roundtable. Colorectal cancer screening rates in community health center patients. American Cancer Society. Accessed January 23, 2025. https:\/\/nccrt.org\/our-impact\/data-and-progress\/"},{"key":"zoi250859r12","doi-asserted-by":"crossref","unstructured":"de Lima? PN, Rutter? CM, Maerzluft? C, Ozik? J, Collier? N. Robustness analysis of colorectal cancer colonoscopy screening strategies.? medRxiv. Preprint posted online March 9, 2023. doi:10.1101\/2023.03.07.23286939","DOI":"10.1101\/2023.03.07.23286939"},{"key":"zoi250859r16","unstructured":"U. S. Census Bureau. Data from: annual estimates of the resident population by single year of age and sex for the United States: April 1, 2020 to July 1, 2022. Accessed August 13, 2025. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-national-detail.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2838484\/issaka_2025_oi_250859_1756326523.9333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:31:35Z","timestamp":1756999895000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2838484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.30515","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}